Journal article
Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature
Abstract
Objective The purpose of this study was to characterize the role of eculizumab, a monoclonal antibody against the terminal complement component C5, in patients with catastrophic antiphospholipid syndrome (CAPS). Methods We present a case report of a patient with systemic lupus erythematosus (SLE) and CAPS treated with eculizumab, as well as results of a systematic review of the literature. Results Including our patient, we identified 11 …
Authors
Skoczynska M; Crowther MA; Chowaniec M; Ponikowska M; Chaturvedi S; Legault K
Journal
Lupus, Vol. 29, No. 6, pp. 631–639
Publisher
SAGE Publications
Publication Date
May 2020
DOI
10.1177/0961203320917460
ISSN
0961-2033